Proteasome Regulators: Activators and Inhibitors
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
931-939
Author(s):
Li Huang and Chin Ho Chen
Agonist-Trafficking and Hallucinogens
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
1017-1027
Author(s):
Javier Gonzalez-Maeso and Stuart C. Sealfon
Spermine Metabolism and Anticancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
118-130
Author(s):
R. Amendola, M. Cervelli, E. Fratini, F. Polticelli, D. E. Sallustio and P. Mariottini
Targeting Myc in Pediatric Malignancies of the Central and Peripheral Nervous System
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
176-188
Author(s):
Michael A. Grotzer, Deborah Castelletti, Giulio Fiaschetti, Tarek Shalaby and Alexandre Arcaro
Elucidation of the Molecular Mechanisms of a Salicylhydrazide Class of Compounds by Proteomic Analysis
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
189-201
Author(s):
Xuefei Cao, Carmen Plasencia, Atsuko Kanzaki, Austin Yang, Terrence R. Burke Jr. and Nouri Neamati
Nitric Oxide: Cancer Target or Anticancer Agent?
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
214-236
Author(s):
Simone Mocellin
Cancer Drug Development with the Help of Radiopharmaceuticals: Academic Experience
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
950-956
Author(s):
Steven M. Larson
Prodigiosins as Anti Cancer Agents: Living Upto Their Name
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
732-741
Author(s):
R. Pandey, R. Chander and K. B. Sainis
Chemokine Receptors as Targets for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
742-757
Author(s):
Xuesong Wu, Vivian C. Lee, Eric Chevalier and Sam T. Hwang
Receptor Tryosine Kinase Inhibitors as Potent Weapons in War Against Cancers
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
758-776
Author(s):
P. Sapra Sharma, R. Sharma and T. Tyagi